Neurify Biosciences is a consulting firm empowering biotech companies with expert guidance in neurodegeneration and advanced disease modeling. We specialize in human-relevant systems—organ chips, iPSC-derived models, and other New Approach Methodologies (NAMs)—to bridge the gap between preclinical research and translational strategy.
With recent FDA and NIH momentum behind NAMs, including regulatory acceptance of organ-on-chip data and expanded NIH support, we help clients de-risk programs, design predictive assays, and align with the next generation of non-animal, human-based drug development tools.
Driving innovation from bench to bedside—smarter, faster, and more human-relevant.
Company Details
- Employees
- 1
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- https://www.neurifybio.com
Neurify Biosciences Questions
Neurify Biosciences's website is https://www.neurifybio.com
Neurify Biosciences's LinkedIn profile is https://www.linkedin.com/company/neurify-biosciences
Neurify Biosciences has
1 employees.
View email and phone details for 1
employees at Neurify Biosciences.
Neurify Biosciences's industry is
Business Consulting and Services
Neurify Biosciences's top competitors are
Thera Phragma,
Reneurocell Therapeutics,
Neuphoria Therapeutics Inc,
Encephalos Life Sciences Llc,
Neuphoria Tms,
Megadalton Solutions,
Vigil Neuroscience,
Phragma Therapeutics,
Mariposa Therapeutics,
Technopharmasphere.
Neurify Biosciences's categories are Business Consulting and Services
